Bristol Myers Squibb Co SEC filings BMY
Bristol Myers Squibb Co has 1,002 filings in SEC EDGAR's recent list, going back to Apr 2, 2019. Its latest annual report, Form ARS, was filed on Mar 25, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 29, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 29, 2026 | Oct 29, 2026 |
| 10-Q | Quarterly report | Jul 30, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 30, 2026 | Jul 30, 2026 |
| 11-K | Employee savings plan report | Jun 5, 2026 | Dec 31, 2025 |
| 11-K | Employee savings plan report | Jun 5, 2026 | Dec 31, 2025 |
| 11-K | Employee savings plan report | Jun 5, 2026 | Dec 31, 2025 |
| S-8 | Employee stock plan registration | May 8, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
May 8, 2026 | May 5, 2026 |
| 10-Q | Quarterly report | Apr 30, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 30, 2026 | Apr 30, 2026 |
| DEFA14A | Additional proxy material | Apr 17, 2026 | — |
| 15-12G | Deregistration | Mar 27, 2026 | — |
| ARS | Annual report to shareholders | Mar 25, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Mar 25, 2026 | — |
| DEF 14A | Proxy statement | Mar 25, 2026 | May 5, 2026 |
| 10-K | Annual report | Feb 11, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 5, 2026 | Feb 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Other events
|
Nov 18, 2025 | Nov 17, 2025 |
| CERT | Nyse certification | Nov 12, 2025 | — |
| 8-A12B | Filing | Nov 10, 2025 | — |
| 8-K |
Current report
Other events
|
Nov 10, 2025 | Oct 31, 2025 |
| 424B5 | Prospectus supplement | Nov 7, 2025 | — |
| FWP | Free writing prospectus | Nov 5, 2025 | — |
| 8-K |
Current report
Other events
|
Nov 3, 2025 | Nov 3, 2025 |
| 424B2 | Prospectus | Nov 3, 2025 | — |
| POSASR | Filing | Oct 31, 2025 | — |
| 10-Q | Quarterly report | Oct 30, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 30, 2025 | Oct 30, 2025 |
| 10-Q | Quarterly report | Jul 31, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 31, 2025 | Jul 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 25, 2025 | Jul 21, 2025 |
| 11-K | Employee savings plan report | Jun 6, 2025 | Dec 31, 2024 |
| 11-K | Employee savings plan report | Jun 6, 2025 | Dec 31, 2024 |
| 11-K | Employee savings plan report | Jun 6, 2025 | Dec 31, 2024 |
| 25-NSE | Delisting notice | May 15, 2025 | — |
| SC TO-T/A | Filing | May 13, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
May 7, 2025 | May 6, 2025 |
| SC TO-T/A | Filing | May 6, 2025 | — |
| SC TO-T/A | Filing | May 5, 2025 | — |
| 10-Q | Quarterly report | Apr 24, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 24, 2025 | Apr 24, 2025 |
| SC TO-T/A | Filing | Apr 23, 2025 | — |
| SC TO-T/A | Sc-to-t/a | Apr 17, 2025 | — |
| DEFA14A | Additional proxy material | Apr 15, 2025 | — |
| SC TO-T | Filing | Apr 14, 2025 | — |
| ARS | Annual report to shareholders | Mar 26, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Mar 26, 2025 | — |
| DEF 14A | Proxy statement | Mar 26, 2025 | Dec 31, 2024 |
| SC TO-C | Filing | Mar 13, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Feb 18, 2025 | Feb 14, 2025 |
| 10-K | Annual report | Feb 12, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 6, 2025 | Feb 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| S-3ASR | Automatic shelf registration | Dec 13, 2024 | — |
| 10-Q | Quarterly report | Oct 31, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 31, 2024 | Oct 31, 2024 |
| 10-Q | Quarterly report | Jul 26, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 26, 2024 | Jul 26, 2024 |
| 11-K | Employee savings plan report | Jun 25, 2024 | Dec 31, 2023 |
| 11-K | Employee savings plan report | Jun 25, 2024 | Dec 31, 2023 |
| 11-K | Employee savings plan report | Jun 25, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Officer or director change
|
Jun 18, 2024 | Jun 18, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 9, 2024 | May 7, 2024 |
| 10-Q | Quarterly report | Apr 25, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 25, 2024 | Apr 25, 2024 |
| DEFA14A | Additional proxy material | Apr 22, 2024 | — |
| ARS | Annual report to shareholders | Mar 28, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Mar 28, 2024 | — |
| DEF 14A | Proxy statement | Mar 28, 2024 | May 7, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 18, 2024 | Mar 13, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 18, 2024 | May 7, 2024 |
| 8-K |
Current report
Other events
|
Mar 18, 2024 | Mar 18, 2024 |
| SC TO-T/A | Filing | Feb 23, 2024 | — |
| 8-K |
Current report
Other events
|
Feb 22, 2024 | Feb 14, 2024 |
| 424B5 | Prospectus supplement | Feb 16, 2024 | — |
| CORRESP | Letter to the SEC | Feb 16, 2024 | — |
| SC TO-T/A | Filing | Feb 16, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Feb 15, 2024 | Feb 13, 2024 |
| FWP | Free writing prospectus | Feb 15, 2024 | — |
| 8-K |
Current report
Other events
|
Feb 14, 2024 | Feb 14, 2024 |
| 10-K | Annual report | Feb 13, 2024 | Dec 31, 2023 |
| 424B2 | Prospectus | Feb 13, 2024 | — |
| SC TO-T/A | Filing | Feb 12, 2024 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 2, 2024 | Feb 2, 2024 |
| SC TO-T | Filing | Jan 25, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| SC TO-C | Filing | Dec 26, 2023 | — |
| DFAN14A | Filing | Dec 22, 2023 | — |
| DFAN14A | Filing | Dec 22, 2023 | — |
| 8-K |
Current report
Other events
|
Dec 22, 2023 | Dec 22, 2023 |
| 8-K |
Current report
Other events
|
Nov 13, 2023 | Oct 30, 2023 |
| 424B5 | Prospectus supplement | Nov 1, 2023 | — |
| 8-K/A |
Amended current report
Officer or director change
|
Oct 31, 2023 | Apr 21, 2023 |
| FWP | Free writing prospectus | Oct 30, 2023 | — |
| 424B3 | Prospectus | Oct 30, 2023 | — |
| 10-Q | Quarterly report | Oct 26, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 26, 2023 | Oct 26, 2023 |
| DFAN14A | Filing | Oct 10, 2023 | — |
| 8-K |
Current report
Other events
|
Aug 10, 2023 | Aug 9, 2023 |
| 10-Q | Quarterly report | Jul 27, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 27, 2023 | Jul 27, 2023 |
| 11-K | Employee savings plan report | Jun 8, 2023 | Dec 31, 2022 |
| 11-K | Employee savings plan report | Jun 8, 2023 | Dec 31, 2022 |
| 11-K | Employee savings plan report | Jun 8, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 4, 2023 | May 2, 2023 |
| 10-Q | Quarterly report | Apr 27, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 27, 2023 | Apr 27, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Apr 26, 2023 | Apr 21, 2023 |
| DEFA14A | Additional proxy material | Apr 10, 2023 | — |
| ARS | Annual report to shareholders | Mar 23, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Mar 23, 2023 | — |
| DEF 14A | Proxy statement | Mar 23, 2023 | — |
| 8-K |
Current report
Other events
|
Feb 28, 2023 | Feb 23, 2023 |
| 10-K | Annual report | Feb 14, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 2, 2023 | Feb 2, 2023 |
| 8-K |
Current report
Officer or director change
|
Jan 31, 2023 | Jan 29, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 10-Q | Quarterly report | Oct 26, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 26, 2022 | Oct 25, 2022 |
| SC TO-T/A | Sc to-ta | Aug 16, 2022 | — |
| SC TO-T/A | Sc to-ta | Aug 9, 2022 | — |
| 10-Q | Quarterly report | Jul 27, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 27, 2022 | Jul 27, 2022 |
| SC TO-T/A | Filing | Jul 19, 2022 | — |
| SC TO-T/A | Filing | Jul 1, 2022 | — |
| SC TO-T | Sc tot | Jun 17, 2022 | — |
| 11-K | Employee savings plan report | Jun 16, 2022 | Dec 31, 2021 |
| 11-K | Employee savings plan report | Jun 16, 2022 | Dec 31, 2021 |
| 11-K | Employee savings plan report | Jun 16, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Officer or director change
|
Jun 15, 2022 | Jun 14, 2022 |
| SC TO-C | Filing | Jun 3, 2022 | — |
| 8-K |
Current report
Shareholder vote results
|
May 5, 2022 | May 3, 2022 |
| 10-Q | Quarterly report | Apr 29, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 29, 2022 | Apr 29, 2022 |
| DEFA14A | Additional proxy material | Apr 20, 2022 | — |
| 8-K |
Current report
Results of operations
|
Apr 18, 2022 | Apr 18, 2022 |
| UPLOAD | Letter from the SEC | Apr 8, 2022 | — |
| CORRESP | Letter to the SEC | Apr 6, 2022 | — |
| PX14A6G | Filing | Apr 5, 2022 | — |
| DEFA14A | Additional proxy material | Mar 24, 2022 | — |
| DEF 14A | Proxy statement | Mar 24, 2022 | May 3, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 17, 2022 | Mar 14, 2022 |
| 8-K |
Current report
Other events
|
Mar 3, 2022 | Mar 1, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 2, 2022 | Mar 2, 2022 |
| 8-K |
Current report
Other events
|
Feb 24, 2022 | Feb 18, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 22, 2022 | Feb 15, 2022 |
| 424B5 | Prospectus supplement | Feb 17, 2022 | — |
| FWP | Free writing prospectus | Feb 15, 2022 | — |
| 8-K |
Current report
Other events
|
Feb 15, 2022 | Feb 15, 2022 |
| 424B3 | Prospectus | Feb 15, 2022 | — |
| 10-K | Annual report | Feb 9, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Other events
|
Feb 9, 2022 | Feb 8, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 4, 2022 | Feb 4, 2022 |
| CORRESP | Letter to the SEC | Jan 18, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2022 | Jan 10, 2022 |
| UPLOAD | Letter from the SEC | Dec 16, 2021 | — |
| S-3ASR | Automatic shelf registration | Dec 13, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 16, 2021 | Nov 16, 2021 |
| 10-Q | Quarterly report | Oct 27, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 27, 2021 | Oct 27, 2021 |
| 8-K |
Current report
Officer or director change
|
Aug 9, 2021 | Aug 3, 2021 |
| 10-Q | Quarterly report | Jul 28, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 28, 2021 | Jul 28, 2021 |
| 11-K | Employee savings plan report | Jun 16, 2021 | Dec 31, 2020 |
| 11-K | Employee savings plan report | Jun 16, 2021 | Dec 31, 2020 |
| 11-K | Employee savings plan report | Jun 16, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Officer or director change
|
May 20, 2021 | May 14, 2021 |
| 8-K |
Current report
Shareholder vote results
|
May 6, 2021 | May 4, 2021 |
| S-8 | Employee stock plan registration | May 4, 2021 | — |
| S-8 POS | Filing | May 4, 2021 | — |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
May 4, 2021 | May 4, 2021 |
| 10-Q | Quarterly report | Apr 29, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 29, 2021 | Apr 29, 2021 |
| DEFA14A | Additional proxy material | Apr 19, 2021 | — |
| PX14A6G | Filing | Apr 12, 2021 | — |
| DEFA14A | Additional proxy material | Mar 25, 2021 | — |
| DEF 14A | Proxy statement | Mar 25, 2021 | May 4, 2021 |
| PRE 14A | Preliminary proxy statement | Mar 12, 2021 | May 4, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 4, 2021 | Mar 1, 2021 |
| 8-K |
Current report
Other events
|
Feb 23, 2021 | Feb 19, 2021 |
| 8-K |
Current report
Other events
|
Feb 22, 2021 | Feb 18, 2021 |
| 8-K |
Current report
Officer or director change
|
Feb 10, 2021 | Feb 10, 2021 |
| 10-K | Annual report | Feb 10, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Other events
|
Feb 4, 2021 | Feb 4, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 4, 2021 | Feb 4, 2021 |
| 8-K |
Current report
Agreement ended
|
Feb 2, 2021 | Feb 2, 2021 |
| UPLOAD | Letter from the SEC | Feb 1, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 11, 2021 | Jan 11, 2021 |
| 25-NSE/A | Filing | Jan 7, 2021 | — |
| CORRESP | Letter to the SEC | Jan 6, 2021 | — |
| 25-NSE | Delisting notice | Jan 4, 2021 | — |
| 8-K |
Current report
Other events
|
Jan 4, 2021 | Jan 1, 2021 |
| UPLOAD | Letter from the SEC | Dec 22, 2020 | — |
| 8-K |
Current report
Other events
|
Nov 17, 2020 | Nov 17, 2020 |
| SC TO-T/A | Filing | Nov 17, 2020 | — |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Nov 13, 2020 | Nov 13, 2020 |
| 424B5 | Prospectus supplement | Nov 12, 2020 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BMY (NYSE), CELG-RI (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Princeton, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 14272
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.